Amirpour Z, Bahari A, Nafisi B, Rahmani K, Taghipour Zahir S, Shahid Sadoughi General Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. (2020) Prognosis and survival study in patients with Glioblastoma Multiform and its relationship with EGFR expression. Iran J Neurosurg 6(3):113–120. https://doi.org/10.32598/irjns.6.3.2

Article  Google Scholar 

Amit D, Matouk IJ, Lavon I, Birman T, Galula J, Abu-Lail R, Schneider T, Siegal T, Hochberg A, Fellig Y (2012) Transcriptional targeting of glioblastoma by diphtheria toxin-A driven by both H19 and IGF2-P4 promoters. Int J Clin Exp Med 5(2):124–135

CAS  PubMed  PubMed Central  Google Scholar 

An Z, Aksoy O, Zheng T, Fan Q-W, Weiss WA (2018) Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies. Oncogene 37(12):1561–1575. https://doi.org/10.1038/s41388-017-0045-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andersson ER, Sandberg R, Lendahl U (2011) Notch signaling: simplicity in design, versatility in function. Development 138(17):3593–3612. https://doi.org/10.1242/dev.063610

Article  CAS  PubMed  Google Scholar 

Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, Ichimura K (2013) Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss. Acta Neuropathol 126(2):267–276. https://doi.org/10.1007/s00401-013-1141-6

Article  CAS  PubMed  Google Scholar 

Arvanitis D, Malliri A, Antoniou D, Linardopoulos S, Field JK, Spandidos DA (1991) Ras p21 expression in brain tumors: elevated expression in malignant astrocytomas and glioblastomas multiforme. In vivo (Athens Greece) 5(4):317–321

CAS  PubMed  Google Scholar 

Assem M, Sibenaller Z, Agarwal S, Al-Keilani MS, Alqudah MAY, Ryken TC (2012) Enhancing diagnosis, prognosis, and therapeutic outcome prediction of Gliomas using Genomics. OMICS 16(3):113–122. https://doi.org/10.1089/omi.2011.0031

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aubry M, De Tayrac M, Etcheverry A, Clavreul A, Saikali S, Menei P, Mosser J (2015) From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity. Oncotarget 6(14):12094–12109. https://doi.org/10.18632/oncotarget.3297

Article  PubMed  PubMed Central  Google Scholar 

Baba AB, Rah B, Bhat GR, Mushtaq I, Parveen S, Hassan R, Hameed Zargar M, Afroze D (2022) Transforming growth factor-Beta (TGF-β) signaling in Cancer-A Betrayal within. Front Pharmacol 13:791272. https://doi.org/10.3389/fphar.2022.791272

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bar EE, Lin A, Mahairaki V, Matsui W, Eberhart CG (2010) Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in Glioblastoma Neurospheres. Am J Pathol 177(3):1491–1502. https://doi.org/10.2353/ajpath.2010.091021

Article  CAS  PubMed  PubMed Central  Google Scholar 

Batista PJ, Chang HY (2013) Long noncoding RNAs: Cellular address codes in development and disease. Cell 152(6):1298–1307. https://doi.org/10.1016/j.cell.2013.02.012

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bazzoni R, Bentivegna A (2019) Role of Notch Signaling Pathway in Glioblastoma Pathogenesis. Cancers 11(3):292. https://doi.org/10.3390/cancers11030292

Article  CAS  PubMed  PubMed Central  Google Scholar 

Belgard TG, Marques AC, Oliver PL, Abaan HO, Sirey TM, Hoerder-Suabedissen A, García-Moreno F, Molnár Z, Margulies EH, Ponting CP (2011) A transcriptomic atlas of mouse neocortical layers. Neuron 71(4):605–616. https://doi.org/10.1016/j.neuron.2011.06.039

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bian E-B, Li J, Xie Y-S, Zong G, Li J, Zhao B (2015) LncRNAs: New players in gliomas, with special emphasis on the interaction of lncRNAs with EZH2. J Cell Physiol 230(3):496–503. https://doi.org/10.1002/jcp.24549

Article  CAS  PubMed  Google Scholar 

Bleeker FE, Lamba S, Zanon C, Molenaar RJ, Hulsebos TJ, Troost D, Van Tilborg AA, Vandertop WP, Leenstra S, Van Noorden CJ, Bardelli A (2014) Mutational profiling of kinases in glioblastoma. BMC Cancer 14(1):718. https://doi.org/10.1186/1471-2407-14-718

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burger PC, Pearl DK, Aldape K, Yates AJ, Scheithauer BW, Passe SM, Jenkins RB, James CD (2001) Small Cell Architecture—A histological equivalent of EGFR amplification in Glioblastoma Multiforme? J Neuropathol Exper Neurol 60(11):1099–1104. https://doi.org/10.1093/jnen/60.11.1099

Article  CAS  Google Scholar 

Burgess R, Jenkins R, Zhang Z (2008) Epigenetic changes in gliomas. Cancer Biol Ther 7(9):1326–1334. https://doi.org/10.4161/cbt.7.9.6992

Article  CAS  PubMed  Google Scholar 

Burr SP, Costa ASH, Grice GL, Timms RT, Lobb IT, Freisinger P, Dodd RB, Dougan G, Lehner PJ, Frezza C, Nathan JA (2016) Mitochondrial protein lipoylation and the 2-Oxoglutarate dehydrogenase Complex Controls HIF1α Stability in Aerobic conditions. Cell Metabol 24(5):740–752. https://doi.org/10.1016/j.cmet.2016.09.015

Article  CAS  Google Scholar 

Butler M, Pongor L, Su Y-T, Xi L, Raffeld M, Quezado M, Trepel J, Aldape K, Pommier Y, Wu J (2020) MGMT Status as a clinical biomarker in Glioblastoma. Trends Cancer 6(5):380–391. https://doi.org/10.1016/j.trecan.2020.02.010

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A, Rinn JL (2011) Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 25(18):1915–1927. https://doi.org/10.1101/gad.17446611

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carén H, Pollard SM, Beck S (2013) The good, the bad and the ugly: epigenetic mechanisms in glioblastoma. Mol Aspects Med 34(4):849–862. https://doi.org/10.1016/j.mam.2012.06.007

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chalhoub N, Baker SJ (2009) PTEN and the PI3-Kinase pathway in Cancer. Annu Rev Pathol 4(1):127–150. https://doi.org/10.1146/annurev.pathol.4.110807.092311

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65(14):6029–6033. https://doi.org/10.1158/0008-5472.CAN-05-0137

Article  CAS  PubMed  Google Scholar 

Chigurupati S, Venkataraman R, Barrera D, Naganathan A, Madan M, Paul L, Pattisapu JV, Kyriazis GA, Sugaya K, Bushnev S, Lathia JD, Rich JN, Chan SL (2010) Receptor Channel TRPC6 is a key mediator of Notch-Driven Glioblastoma Growth and Invasiveness. Cancer Res 70(1):418–427. https://doi.org/10.1158/0008-5472.CAN-09-2654

Article  CAS  PubMed  Google Scholar 

Choi Y, Song Y-J, Lee H-S, Hur W-J, Sung K-H, Kim K-U, Choi S-S, Kim S-J, Kim D-C (2013) Epidermal growth factor receptor is related to poor survival in Glioblastomas: single-Institution experience. Yonsei Med J 54(1):101. https://doi.org/10.3349/ymj.2013.54.1.101

Article  PubMed  Google Scholar 

Chou F-J, Liu Y, Lang F, Yang C (2021) D-2-Hydroxyglutarate in Glioma Biology. Cells 10(9):2345. https://doi.org/10.3390/cells10092345

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ciafrè SA, Galardi S, Mangiola A, Ferracin M, Liu C-G, Sabatino G, Negrini M, Maira G, Croce CM, Farace MG (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334(4):1351–1358. https://doi.org/10.1016/j.bbrc.2005.07.030